Literature DB >> 21697289

Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling.

Danny Bruce1, Sanhong Yu, Jot Hui Ooi, Margherita T Cantorna.   

Abstract

Multiple pathways converge to result in the overexpression of T(h)17 cells in the absence of either vitamin D or the vitamin D receptor (VDR). CD4(+) T cells from VDR knockout (KO) mice have a more activated phenotype than their wild-type (WT) counterparts and readily develop into T(h)17 cells under a variety of in vitro conditions. Vitamin D-deficient CD4(+) T cells also overproduced IL-17 in vitro and 1,25 dihydroxyvitamin D(3) inhibited the development of T(h)17 cells in CD4(+) T-cell cultures. Conversely, the induction of inducible (i) Tregs was lower in VDR KO CD4(+) T cells than WT and the VDR KO iTregs were refractory to IL-6 inhibition. Host-specific effects of the VDR were evident on in vivo development of naive T cells. Development of naive WT CD4(+) T cells in the VDR KO host resulted in the overexpression of IL-17 and more severe experimental inflammatory bowel disease (IBD). The increased expression of T(h)17 cells in the VDR KO mice was associated with a reduction in tolerogenic CD103(+) dendritic cells. The data collectively demonstrate that T(h)17 and iTreg cells are direct and indirect targets of vitamin D. The increased propensity for development of T(h)17 cells in the VDR KO host results in more severe IBD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697289      PMCID: PMC3139478          DOI: 10.1093/intimm/dxr045

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  39 in total

1.  TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells.

Authors:  Lyudmila A Lyakh; Michael Sanford; Sebel Chekol; Howard A Young; Anita B Roberts
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

2.  Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

Authors:  Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin
Journal:  Science       Date:  2006-02-23       Impact factor: 47.728

3.  1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease.

Authors:  M T Cantorna; C Munsick; C Bemiss; B D Mahon
Journal:  J Nutr       Date:  2000-11       Impact factor: 4.798

4.  Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo.

Authors:  M D Griffin; W Lutz; V A Phan; L A Bachman; D J McKean; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

5.  Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.

Authors:  H Defacque; C Sévilla; D Piquemal; C Rochette-Egly; J Marti; T Commes
Journal:  Leukemia       Date:  1997-02       Impact factor: 11.528

6.  IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.

Authors:  David Yen; Jeanne Cheung; Heleen Scheerens; Frédérique Poulet; Terrill McClanahan; Brent McKenzie; Melanie A Kleinschek; Alex Owyang; Jeanine Mattson; Wendy Blumenschein; Erin Murphy; Manjiri Sathe; Daniel J Cua; Robert A Kastelein; Donna Rennick
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

7.  All-trans retinoic acid antagonizes the action of calciferol and its active metabolite, 1,25-dihydroxycholecalciferol, in rats.

Authors:  Cynthia M Rohde; Hector F DeLuca
Journal:  J Nutr       Date:  2005-07       Impact factor: 4.798

8.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

9.  A unique subset of self-specific intraintestinal T cells maintains gut integrity.

Authors:  Philippe Poussier; Terri Ning; Diponkar Banerjee; Michael Julius
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  56 in total

Review 1.  Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors?

Authors:  Jot Hui Ooi; Jing Chen; Margherita T Cantorna
Journal:  Mol Aspects Med       Date:  2011-11-06

Review 2.  The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases.

Authors:  Benjamin V Park; Fan Pan
Journal:  Cell Mol Immunol       Date:  2015-09       Impact factor: 11.530

Review 3.  Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).

Authors:  Daniel J Raiten; Fayrouz A Sakr Ashour; A Catharine Ross; Simin N Meydani; Harry D Dawson; Charles B Stephensen; Bernard J Brabin; Parminder S Suchdev; Ben van Ommen
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

Review 4.  Anti-Saccharomyces cerevisiae autoantibodies in autoimmune diseases: from bread baking to autoimmunity.

Authors:  Maurizio Rinaldi; Roberto Perricone; Miri Blank; Carlo Perricone; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 5.  Metabolic control of the Treg/Th17 axis.

Authors:  Joseph Barbi; Drew Pardoll; Fan Pan
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

6.  Invariant NKT cell defects in vitamin D receptor knockout mice prevents experimental lung inflammation.

Authors:  Sanhong Yu; Jun Zhao; Margherita T Cantorna
Journal:  J Immunol       Date:  2011-09-23       Impact factor: 5.422

7.  IBD: Vitamin D and IBD: moving towards clinical trials.

Authors:  Margherita T Cantorna
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-05-05       Impact factor: 46.802

8.  Vitamin D3 receptor polymorphisms regulate T cells and T cell-dependent inflammatory diseases.

Authors:  Gonzalo Fernandez Lahore; Bruno Raposo; Marie Lagerquist; Claes Ohlsson; Pierre Sabatier; Bingze Xu; Mike Aoun; Jaime James; Xiaojie Cai; Roman A Zubarev; Kutty Selva Nandakumar; Rikard Holmdahl
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

Review 9.  Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review.

Authors:  Krista M Reich; Richard N Fedorak; Karen Madsen; Karen I Kroeker
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

10.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.